ELUT
Price
$0.95
Change
+$0.05 (+5.56%)
Updated
Aug 21 closing price
Capitalization
42.11M
85 days until earnings call
Intraday BUY SELL Signals
STRR
Price
$10.01
Change
+$0.01 (+0.10%)
Updated
Aug 21 closing price
Capitalization
36.78M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELUT vs STRR

ELUT vs STRR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELUT vs. STRR commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a Hold and STRR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (ELUT: $0.95 vs. STRR: $10.01)
Brand notoriety: ELUT and STRR are both not notable
ELUT represents the Medical/Nursing Services, while STRR is part of the Other Consumer Services industry
Current volume relative to the 65-day Moving Average: ELUT: 2% vs. STRR: 19%
Market capitalization -- ELUT: $42.11M vs. STRR: $36.78M
ELUT [@Medical/Nursing Services] is valued at $42.11M. STRR’s [@Other Consumer Services] market capitalization is $36.78M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $201.83B to $0. The market cap for tickers in the [@Other Consumer Services] industry ranges from $18.76B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $6.08B. The average market capitalization across the [@Other Consumer Services] industry is $1.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 1 FA rating(s) are green whileSTRR’s FA Score has 1 green FA rating(s).

  • ELUT’s FA Score: 1 green, 4 red.
  • STRR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELUT and STRR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 5 TA indicator(s) are bullish while STRR’s TA Score has 5 bullish TA indicator(s).

  • ELUT’s TA Score: 5 bullish, 5 bearish.
  • STRR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ELUT and STRR are a good buy in the short-term.

Price Growth

ELUT (@Medical/Nursing Services) experienced а +1.05% price change this week, while STRR (@Other Consumer Services) price change was -0.94% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +6.51%, and the average quarterly price growth was -7.37%.

The average weekly price growth across all stocks in the @Other Consumer Services industry was -1.25%. For the same industry, the average monthly price growth was +4.50%, and the average quarterly price growth was +41.93%.

Reported Earning Dates

ELUT is expected to report earnings on Nov 16, 2026.

STRR is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.94% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Other Consumer Services (-1.25% weekly)

Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELUT($42.1M) has a higher market cap than STRR($36.8M). ELUT YTD gains are higher at: 37.274 vs. STRR (-11.067). STRR has higher annual earnings (EBITDA): -3.24M vs. ELUT (-20.21M). ELUT has more cash in the bank: 28.5M vs. STRR (12.2M). ELUT has less debt than STRR: ELUT (4.22M) vs STRR (26.7M). STRR has higher revenues than ELUT: STRR (190M) vs ELUT (12.5M).
ELUTSTRRELUT / STRR
Capitalization42.1M36.8M114%
EBITDA-20.21M-3.24M623%
Gain YTD37.274-11.067-337%
P/E RatioN/AN/A-
Revenue12.5M190M7%
Total Cash28.5M12.2M234%
Total Debt4.22M26.7M16%
FUNDAMENTALS RATINGS
ELUT vs STRR: Fundamental Ratings
ELUT
STRR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELUT's Valuation (29) in the null industry is significantly better than the same rating for STRR (95) in the Medical Specialties industry. This means that ELUT’s stock grew significantly faster than STRR’s over the last 12 months.

ELUT's Profit vs Risk Rating (100) in the null industry is in the same range as STRR (100) in the Medical Specialties industry. This means that ELUT’s stock grew similarly to STRR’s over the last 12 months.

STRR's SMR Rating (96) in the Medical Specialties industry is in the same range as ELUT (100) in the null industry. This means that STRR’s stock grew similarly to ELUT’s over the last 12 months.

STRR's Price Growth Rating (61) in the Medical Specialties industry is in the same range as ELUT (64) in the null industry. This means that STRR’s stock grew similarly to ELUT’s over the last 12 months.

STRR's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for ELUT (100) in the null industry. This means that STRR’s stock grew significantly faster than ELUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELUTSTRR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 10 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ELUT
Daily Signal:
Gain/Loss:
STRR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGCX10.370.12
+1.17%
Virtus KAR Small-Cap Growth C
MLPSX103.930.65
+0.63%
ProFunds Mid Cap Value Svc
VMACX56.460.33
+0.59%
Virtus KAR Mid-Cap Core A
TLAFX12.780.05
+0.39%
Transamerica Large Core ESG R4
JFNNX92.33N/A
N/A
Janus Henderson Global Life Sciences N

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and XAIR have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and XAIR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
+5.44%
XAIR - ELUT
30%
Poorly correlated
-2.33%
STRRP - ELUT
23%
Poorly correlated
+2.09%
STRR - ELUT
23%
Poorly correlated
+0.05%
HSDT - ELUT
23%
Poorly correlated
+12.90%
RPID - ELUT
23%
Poorly correlated
+0.60%
More

STRR and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRR has been closely correlated with CATX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRR jumps, then CATX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRR
1D Price
Change %
STRR100%
+0.05%
CATX - STRR
88%
Closely correlated
+2.80%
NSYS - STRR
29%
Poorly correlated
+4.60%
CERS - STRR
23%
Poorly correlated
+0.72%
LUNG - STRR
23%
Poorly correlated
-1.74%
MODD - STRR
22%
Poorly correlated
+3.21%
More